Skip to main content
OpenTrials
Completed

NCT Number: NCT05383235

Facial Emotion Recognition in Patients Who Committed Sexual Assault Against Children: an EEG Study

This study aims to compare the emotional processing in sexual offenders against children versus healthy volunteers using an objective electrophysiological measurement (EEG) during a facial emotion stimuli presentation task. Secondary goal is to assess emotion recognition performances in this population and evaluate the impact of various factors on these performances (type of emotion, age and sex of person expressing the emotion, neuropsychological and cognitive abilities of the subjects).

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–55 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Centre Hospitalier Le Vinatier

Bron, Auvergne-Rhône-Alpes, 69678, France

About this study

Sexual abuse is a major public health issue. Apart from medical care of victims, it appears essential to intervene with sexual offenders for prevention purposes (from primary prevention to avoid a first sexual abuse to secondary and tertiary prevention to avoid recurrence). In order to improve those prevention strategies, further understanding of offenders neuropsychological and cognitive processes is needed.

Facial emotion recognition capacities, that play a major role in social cognition and generation of appropriate social behavior, has been the subject of few studies in sexual offenders. These studies show heterogeneous results and only one of them specifically targets sexual offenders against children. Furthermore, no study has investigated facial emotion recognition in this population with an objective measurement of emotional processing, such as electroencephalographic (EEG) activity. LPP (late positive potential) amplitude, measured in EEG, is a marker of emotional processing and appears to be modified in particular populations (eg. psychopaths) in response to negative visual stimuli compared to positive stimuli.

The investigators aim to determine whether LPP amplitude in response to negative facial expressions is modified in sexual offenders against children compared to healthy volunteers and compared to amplitude in response to positive facial expressions.

Effect of facial emotion characteristics (type of emotion, age and sex of person expressing the emotion) on EEG response will be assessed.

Various neuropsychological and cognitive characteristics (facial emotion recognition, theory of mind, psychopathic traits, childhood trauma, and alexithymia) of patients and controls will also be measured through neuropsychological evaluation and completion of scales and questionnaires, in order to investigate the impact of those factors on facial emotion recognition performances.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

SUBJECTS - Sexual offenders against children:

  • Right-handed ;
  • Patient refered to the referral platform for treatment of sexual offenders in Le Vinatier Hospital Center for evaluation of child abuse ;
  • Without any Axis 1 disorder ;
  • Having given informed consent ;
  • Affiliated to French social health care

Exclusion criteria

  • Intellectual disability (identified during routine care in the referral platform for treatment of sexual offenders);
  • Poor understanding of tests and scales instructions ;
  • Neurological or neurodevelopmental history resulting in cognitive impairment with loss of autonomy ;
  • Gardianship or other tutelage measure

Healthy controls :

Inclusion criteria

  • Right-handed ;
  • Without criminal background ;
  • Without any DSM-5 psychiatric disorder (past or present, personal or familial in a first-degree relative) ;
  • Non-caregiver employee of Le Vinatier Hospital Center.

Exclusion criteria

  • Intellectual disability (using fNART if clinical suspicion during run-in period);
  • Poor understanding of tests and scales instructions ;
  • Neurological or neurodevelopmental history resulting in cognitive impairment with loss of autonomy ;
  • Gardianship or other tutelage measure.

Treatment and study plan

Routine care

Other
  • ROUTINE CARE : retrieval of sociodemographic characteristics, medical and psychological assessment, multidisciplinary meeting about the patient

Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition task

Device
  • RUN-IN PERIOD :
  • Eligibility criteria will be assessed during the multidisciplinary meeting;
  • Study presentation, delivery of the information note and consent form; 3. STUDY:
  • Collection of consent form;
  • Facial emotion stimuli presentation task with EEG recording and facial emotion recording task;
  • Neuropsychological evaluation (TOM-15);
  • Scales and questionnaires (TAS-20, PCL-R SV, CECAQ, QCAE);
  • Debriefing.

Other names: Neuropsychological evaluation

Primary outcomes

  1. Amplitude of LPP during the facial emotion stimuli presentation task

    Time frame: one day

    The facial emotion stimuli presentation task is based on pictures from the Radbout Faces Database (RaFD). It includes pictures of male and female subjects, adults and children expressing positive, neutral or negative emotion.

    During the task, cerebral activity will be recorded by EEG to measure amplitude and latency of the LPP (Late Positive Potential).

Secondary outcomes

  1. Facial emotion recognition abilities

    Time frame: one day

    Subjects and controls will be presented with facial emotion stimuli from the Radbout Faces Database (RaFD). It includes pictures of male and female subjects, adults and children expressing positive, neutral or negative emotion.

    We will measure recognition abilities (% correct response rate, response time, intensity and valence ratings).

  2. TOM-15 (Theory Of Mind 15)

    Time frame: one day

    validated test for assessment of theory of mind

  3. TAS20 (Toronto Alexithymia Scale 20)

    Time frame: one day

    validated scale for assessment of alexithymia Scores vary from 20/100 (low level of alexithymia) to 100/100 (high level of alexithymia)

  4. PCL-R SV (Psychopathy Checklist Revised - Short Version)

    Time frame: one day

    validated checklist for assessment of psychopathy Scores vary from 0/24 (no psychopathic traits) to 24/24 (high level of psychopathic traits)

  5. QCAE (Questionnaire of Cognitive and Affective Empathy)

    Time frame: one day

    validated questionnaire for assessment of cognitive and affective empathy Affective empathy scores vary from 12/48 (low level of affective empathy) to 48/48 (high level of affective empathy).

    Cognitive empathy scores vary from 19/76 (low level of cognitive empathy) to 76/76 (high level of cognitive empathy).

    Total empathy scores vary from 31/124 (low level of empathy) to 124/124 (high level of empathy).

  6. CECA-Q (Childhood Experiences of Care and Abuse - Questionnaire)

    Time frame: one day

    validated questionnaire for assessment of childhood experience of care and abuse Global parental antipathy scores vary from 20/160 (low level of parental antipathy) to 160/160 (high level of parental antipathy).

    Neglect scores vary from 20/160 (low level of neglect) to 160/160 (high level of neglect).

    Physical abuses scores vary from 0/8 (no physical abuses) to 8/8 (high level of physical abuses during childhood) Scores of sexual abuse vary from 0 (no sexual abuse) à 7 (serious sexual abuse) Prevalence of psychological abuse vary from 0/34 (no psychological abuse) to 34/34 (multiple psychological abuses) Frequence of psychological abuse vary from 0/102 ( no psychological abuse) to 102/102 (frequent psychological abuse)

Sponsors and collaborators

Lead sponsor

Hôpital le Vinatier

Other

Registry information

Acronym: EMOREC

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
May 20, 2022
Registry last updated
Jul 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.